Doctor Iacopo Fabiani

Fondazione Toscana Gabriele Monasterio, Pisa (Italy)

Contributor content

Presentation

Gliflozines in active cancer patients with heart failure: final results on safety and effectiveness in the observational TOSCA trial

Presentation

Left atrial strain in cardiac amyloidosis

$Reverse remodelling criteria to predict cardiovascular death in heart failure with reduced or mid-range ejection fraction$

Presentation

Reverse remodelling criteria to predict cardiovascular death in heart failure with reduced or mid-range ejection fraction

Presentation

Left atrial strain in cardiac amyloidosis

Presentation

Micrornas in different phenotypes of aortic valve stenosis

$Peak cardiac power output-to-left ventricular mass independently predicted the risk of adverse left ventricular remodeling in patients with heart failure and reduced ejection fraction$

Presentation

Peak cardiac power output-to-left ventricular mass independently predicted the risk of adverse left ventricular remodeling in patients with heart failure and reduced ejection fraction

Presentation

The added value of exercise stress echocardiography in heart failure patients: the role of dual evaluation of cardiac index and pulmonary congestion

$Interactive role of diastolic dysfunction and ventricular remodeling in stage A and B heart failure with preserved ejection fraction: impact on clinical practice$

Presentation

Interactive role of diastolic dysfunction and ventricular remodeling in stage A and B heart failure with preserved ejection fraction: impact on clinical practice

$Interactive role of diastolic dysfunction and ventricular remodeling in stage a and b heart failure with preserved ejection fraction: impact on clinical practice$

Presentation

Interactive role of diastolic dysfunction and ventricular remodeling in stage a and b heart failure with preserved ejection fraction: impact on clinical practice

$Peak cardiac power output-to-left ventricular mass independently predicted the risk of adverse left ventricular remodeling in patients with heart failure and reduced ejection fraction$

Presentation

Peak cardiac power output-to-left ventricular mass independently predicted the risk of adverse left ventricular remodeling in patients with heart failure and reduced ejection fraction

Explore sponsored resources

Doctor Iacopo Fabiani

Contributor content

Gliflozines in active cancer patients with heart failure: final results on safety and effectiveness in the observational TOSCA trial

Left atrial strain in cardiac amyloidosis

Reverse remodelling criteria to predict cardiovascular death in heart failure with reduced or mid-range ejection fraction

Left atrial strain in cardiac amyloidosis

Micrornas in different phenotypes of aortic valve stenosis

Peak cardiac power output-to-left ventricular mass independently predicted the risk of adverse left ventricular remodeling in patients with heart failure and reduced ejection fraction

The added value of exercise stress echocardiography in heart failure patients: the role of dual evaluation of cardiac index and pulmonary congestion

Interactive role of diastolic dysfunction and ventricular remodeling in stage A and B heart failure with preserved ejection fraction: impact on clinical practice

Interactive role of diastolic dysfunction and ventricular remodeling in stage a and b heart failure with preserved ejection fraction: impact on clinical practice

Peak cardiac power output-to-left ventricular mass independently predicted the risk of adverse left ventricular remodeling in patients with heart failure and reduced ejection fraction

ESC 365 is supported by